The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
Market view
imipenem and cilastatin sodium
7 marketed package NDCs · 2 active manufacturers
Most dispensed: 500 mg/20mL; 500 mg/20mL · Injection, Powder, For Solution · #25 vial, single-doses/carton / 20 ml in 1 vial, single-dose · 250 mg/20mL; 250 mg/20mL · Injection, Powder, For Solution · #25 vial, single-doses/carton / 20 ml in 1 vial, single-dose
What changed in the last 90 days
Every detected change for imipenem and cilastatin sodium, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- Imipenem and CilastatinAug 1, 2026Mfr exitedFresenius Kabi USA, LLC · imipenem and cilastatin sodium
- Imipenem and CilastatinJul 29, 2026Mfr exitedFresenius Kabi USA, LLC · imipenem and cilastatin sodium
- Primaxin IvJul 29, 2026Mfr exitedMerck Sharp & Dohme LLC · imipenem and cilastatin sodium
- Imipenem and CilastatinJul 22, 2026Mfr enteredFresenius Kabi USA, LLC · imipenem and cilastatin sodium
- Primaxin IvJul 22, 2026Mfr enteredMerck Sharp & Dohme LLC · imipenem and cilastatin sodium
- Imipenem and CilastatinJul 22, 2026Mfr enteredFresenius Kabi USA, LLC · imipenem and cilastatin sodium
Same drug class
Other molecules FDA puts in Renal Dehydropeptidase Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Imipenem and cilastatin sodium in shortage right now?
- No. FDA does not currently list Imipenem and cilastatin sodium in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Imipenem and cilastatin sodium?
- 2 companies have marketed Imipenem and cilastatin sodium in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
Shortage reports for this molecule
- Planned discontinuation — Primaxin, Injection, 500mg (NDC 0006-3516-59)Jan 8, 2026
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.